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Abstract Opposing views have been proposed regarding
the role of tau, the principalmicrotubule-associated protein in
axons. On the one hand, tau forms cross-bridges at the
interface between microtubules and induces microtubule
bundling in neurons.On the other hand, tau is also considered
a polymer brush which efficiently separates microtubules. In
mature axons, microtubules are indeed arranged in parallel
arrays and are well separated from each other. To reconcile
these views, we developed a mechanistic model based on
in vitro and cellular approaches combined to analytical and
numerical analyses. The results indicate that tau forms long-
range cross-bridges between microtubules under macro-
molecular crowding conditions. Tau cross-bridges prevent
the redistribution of tau away from the interface between
microtubules, which would have occurred in the polymer
brush model. Consequently, the short-range attractive force
between microtubules induced by macromolecular crowding
is avoided and thus microtubules remain well separated from
each other. Interestingly, in this unified model, tau diffusion
on microtubules enables to keep microtubules evenly dis-
tributed in axonal sections at low tau levels.
Keywords Alzheimer  Tauopathy  Cytoskeleton 
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Introduction
Tau has been the subject of extensive studies by the past
owing to its central role in many neurodegenerative dis-
eases including Alzheimer’s disease [1–6]. However,
despite the in-depth study of tau functions in neurons, both
its regulatory role in axonal architecture and its contribu-
tion to neurodegeneration remain open questions. In the
most popular model, tau stabilizes microtubules in axons
[6–15]. During neuronal degeneration, tau is phosphory-
lated and possibly released from microtubules, which may
then destabilize axonal microtubules [12–15]. Here, we
examine whether tau is specifically designed to prevent the
formation of axonal microtubule bundles. Indeed, axonal
microtubules are well separated in transverse sections of
mature neurons [16–20]. This alternative role for tau has
already been proposed by others based on the polymer
brush model [21–23] but has not truly emerged in the
scientific community. Tau is rather known to form micro-
tubule bundles via complementary dimerization in between
microtubules [24–26], which is hard to reconcile with its
role as microtubule spacer. In addition, a continuous
repulsive layer of tau on microtubules is required to keep
microtubules separated in the polymer brush model [21–23,
27], which is most probably not relevant to the conditions
found in axons. This point is even more critical since tau
diffuses on microtubules [28] and thus has the possibility to
move away from the interface between microtubules.
Besides these diverging views, studying whether tau
keeps microtubules well separated in axons makes sense
for two reasons: (1) their cylindrical geometry and rigid
structure make microtubules prone to collapse due to short-
range (\5 nm) excluded volume interactions in the crow-
ded cellular environment [29, 30]; (2) the organization of
axonal microtubules into parallel arrays significantly
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increases the probability of microtubule bundling in axons.
From a functional point of view, the surface of isolated
microtubules is more accessible than in bundles. Keeping
microtubules separated should then favor the accessibility
of molecular motors to microtubule surface and thus the
long-range transport of cargoes [20].
Here we propose and examine an alternative mecha-
nistic model which reconciles tau-mediated microtubule
bundling observed in vitro and the proposed physiological
function of tau as a microtubule spacer. Indeed we describe
how the formation of transient tau cross-bridges at the
interface between parallel microtubules could lead to a
very efficient separation of microtubules in axons. In
addition, in this model, tau diffusion on microtubules
enables an efficient separation of microtubules even at low
tau levels, more in line with those found in axons.
Results
Analysis of the state of art and clarifications
Four points need to be clarified from the rich literature on
tau and provide a basis for the present study:
1. In the literature, the fact that tau leads to the formation
of microtubule bundles has been reported many times.
Tau is then considered to be a positive regulator of
microtubule bundling. This view stems mostly from
the formation of microtubule bundles in neuronal and
non-neuronal mammalian cells over-expressing tau
[25, 26, 31–33]. As the spacing between microtubules
in these bundles matches the length of the N-terminal
domain of tau [31], this was considered as an evidence
that tau can induce microtubule bundling. In line with
this, the N-terminal domain of tau contains alternating
clusters of positive and negative residues and can act
as an antiparallel electrostatic zipper [24]. However, in
electron micrographs of mature axon sections, micro-
tubules appear as homogeneously distributed (for
examples see [16–20]) and have a larger separation
distance than in tau-mediated bundles (about 20 nm
[32]). Along with this, the density of microtubules
estimated from axonal sections in electron micro-
graphs most frequently ranges from about 15 to 160
microtubules per lm2 [16, 17, 34–37]. The mean
spacing between microtubules thus ranges from 79 to
260 nm. These facts indicate that tau-mediated bund-
ling is not prevalent in mature axons. The presence of
axonal microtubule bundles can nevertheless be
observed at early stage during axon differentiation
[34] and in the axon hillock [38] with possible
neuronal functions but this is not the norm.
2. In contrast, tau may act as a polymer brush and keep
microtubules separated from each other. Based on
thermal movements, the unstructured N-terminal
domain of tau leads to a repulsion of entropic origin
between microtubules [21, 23]. The so called ‘‘poly-
mer brush’’ model works as long as tau forms a
continuous repulsive layer on the microtubule surface.
In addition, as recently measured [28, 39], tau is not
immobile on microtubules but rather diffuses along the
microtubule surface (D = 0.15 lm2/s). The conse-
quences of tau diffusion on the putative entropic
repulsion occurring in the polymer brush model need
to be clarified. Indeed diffusing tau can be redis-
tributed away from the interface between
microtubules. In this case, tau could no longer exert
a repulsion force to keep microtubules separated. In
the absence of any additional factors, only an elevated
tau:tubulin molar ratio and its associated steric
hindrance can prevent tau from moving away from
the interface between microtubules [40], which leaves
the relevancy of this model in axons questionable.
3. The tau:tubulin ratio in axons is actually poorly
characterized. This is highly surprising since this
information is critical to decipher the functions of tau
in axons. In the literature and despite numerous
publications on tau:microtubule interactions, only
limited sources of data have been used to provide an
estimation of the tau:tubulin molar ratio. In micro-
tubules assembled from brain extracts [41], which may
not be representative of axons, the reported tau:tubulin
molar ratio was about 1:12 and 1:38 in gray and white
matters, respectively. In another report [42], the
tau:tubulin measured from undifferentiated to differ-
entiated PC12 cell extracts ranges from about 1:34 to
1:5 and from 1:68 to 1:17. Tau concentration was also
estimated using radioimmuno-slot-blot assay [43].
About 0.9 ng of tau per lg of proteins was found in
postmortem human brain homogenates of grey matter.
If we assume that there is about 30 ng of tubulin per lg
of proteins in brain extract [44], the tau:tubulin molar
ratio in neurons could be lower than 1:30 as grey
matter contains more tubulin than white matter. In
summary, all these data, although useful, do not
provide a precise estimation of the specific tau:tubulin
ratio in axons but rather a global estimation for
neurons or brains. We therefore need to consider this
point in the present study.
4. Microtubules are highly prone to form bundles under
macromolecular crowding conditions. In vitro,
0.3–1 % (w/v) of PEG 35K (polyethylene glycol of
35 kDa), a neutral crowding agent, is sufficient to
trigger microtubule bundling while more than about
10 % of PEG 35K are required for compacting DNA
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under same ionic conditions [29]. Microtubules are
rigid and large cylinders with diameters about 25 nm.
They thus offer a large surface for excluded-volume
interactions. In vitro, microtubule bundles obtained via
excluded-volume interactions under macromolecular
crowding conditions are tightly packed with wall-to-
wall contacts, in contrast with the regularly spaced
microtubules observed in tau-mediated bundles [30].
Microtubule-based transport should most probably be
impaired in such compacted structures [45], which
would be detrimental for most axonal functions.
The role of Tau 2N on microtubule bundling is
biphasic
To reassess tau-mediated bundling in vitro and the impact
of the tau:tubulin molar ratio in microtubule bundling,
microtubule bundling was monitored by turbidimetry
measurements at 37 C [46] in the presence or absence of
tau 2N, the longest tau isoform with four microtubule-
binding domains (Figs. 1a and S1). The results indicate
that tau 2N triggers microtubule bundling in both taxol-
stabilized and non-stabilized microtubules at moderate
ionic strength (Fig. 1b, c). The onset of microtubule
bundling corresponds to a tau:tubulin molar ratio of about
1:30 and microtubule bundling increases steadily at higher
ratios. These results were further confirmed by optical
microscopy and atomic force microscopy analyzes. They
revealed the appearance of aligned microtubules and loose
microtubule bundles in the presence of tau 2N (Figs. 1d, e
and S2). According to the literature, tau cross-bridging at
the interface between two parallel microtubules is due to
the presence of alternating positive and negative charges
located in the N-terminal domain of tau [24]. An electro-
static zipper mechanism is therefore sensitive to the ionic
strength or to the presence of perturbing zwitterions at high
concentrations. In line with this, the presence of PIPES or
MES at elevated concentrations (50 mM) or monovalent
salts ([75 mM) impairs microtubule bundling mediated by
tau 2N (figure S3), which may explain why microtubule
bundling has not been detected in some reports [47, 48], in
contrast to others [24, 49, 50]. We also cannot exclude that
increasing the ionic strength reduces the affinity of tau for
microtubules and, in turn, also reduces the probability to
form tau cross-bridges. Indeed both the formation of tau
cross-bridges and the binding of tau to microtubules are
partly based on electrostatic interactions.
In order to examine the putative role of tau in micro-
tubule bundling under macromolecular crowding
conditions, we used PEG 35K whose size is comparable to
proteins in the cell cytoplasm (about 4–5 nm). 1 % PEG
35K is sufficient to form microtubule bundles (Fig. 2a, c).
This pattern was not observed with PEG 1K because its
size is not sufficient to induce significant excluded volume
interactions [29]. We then analyzed whether tau 2N posi-
tively or negatively regulates the packing of microtubules
under macromolecular crowding conditions. The formation
of microtubule bundles was monitored by turbidimetry
measurements in the presence of tau 2N after the addition
of PEG 35K. The results reveal that tau 2N antagonizes the
collapse of microtubules into tightly packed bundles.
Importantly, at low tau-tubulin molar ratios, 1:30 and to a
lesser extent at 1:60, tau 2N still antagonizes microtubule
bundling (Fig. 2a). Analyzes by optical, atomic force and
electron microscopies further confirm that tau 2N prevents
the formation of tightly packed microtubule bundles under
macromolecular crowding conditions (Fig. 2c–e).
The role of tau 2N in microtubule bundling could thus
be misleading. On the one hand, in the absence of
macromolecular crowding, tau 2N induces the formation of
bundles at elevated tau:tubulin molar ratios. On the other
hand, under macromolecular crowding conditions, tau 2N
antagonizes microtubule bundling and so even at low tau
2N:tubulin molar ratios. Interestingly, at elevated ionic
strength, tau 2N can no longer prevent microtubule bund-
ling in the presence of PEG 35K (Figure S4A). As high
ionic strengths also prevent microtubule bundling mediated
by tau 2N in the absence of PEG 35K (Figure S3), there
could be an unexpected correlation between the formation
of tau cross-bridges between microtubules and the ability
of tau to prevent microtubules from collapsing into tight
bundles under macromolecular conditions.
The N-terminal domain is critical for preventing
microtubule bundling under macromolecular
conditions at low tau:tubulin molar ratio in vitro
To explore the role of the N-terminal domain of tau 2N on
microtubule bundling, we considered three tau constructs
(see Fig. 1a) of different N-terminal length: tau 2N, the
longest tau 4R isoform used as a control, tau 0N, the
smallest isoform of tau 4R, and deltaNT, tau 4R deleted
from its N-terminal domain except part of the proline rich
domain which is critical for the binding of tau to micro-
tubules [51].
In the absence of macromolecular crowding, deltaNT
shows no detectable microtubule bundling activity while
tau 0N could form microtubule bundles but to a lesser
extent than tau 2N (Fig. 1b). DeltaNT also fails to induce
the formation of loose microtubule bundles as observed
with tau 2N (Fig. 1e). The propensity of the tau constructs
to form microtubule bundles thus correlates positively with
the length of the N-terminal domain, which emphasizes the
critical role played by the N-terminal domain of tau in
microtubule bundling in vitro.
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Importantly, under macromolecular crowding condi-
tions, deltaNT cannot prevent microtubule bundling
(Fig. 2b, c, e) and tau 0N limits the formation of micro-
tubule bundles under macromolecular crowding conditions
to a lesser extent than 2N (Fig. 2b). The formation of tau
cross-bridges via the N-terminal domain at the interface
between microtubules is thus possibly critical to prevent
microtubules from collapsing into bundles under
macromolecular conditions, as observed by electron
microscopy (Fig. 2e).
We have also examined whether tau 2N can dissociate
microtubule bundles when they are preformed under
macromolecular conditions. As shown in figure S4B,
microtubules cannot be released from preformed bundles in
the presence of tau 2N. Microtubule bundling under
macromolecular crowding can thus be considered
3748 A. Me´phon-Gaspard et al.
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irreversible regarding to the role of tau as microtubule
spacer. In order to keep microtubules well separated from
each other, tau 2N should therefore be located at the
interface between microtubules before bundling takes
place.
The N-terminal domain of tau antagonizes
microtubule bundling in non-neuronal mammalian
cells at low tau:tubulin fluorescence ratio
In contradiction with the experimental results obtained
under macromolecular crowding conditions in vitro, tau
overexpression in non-neuronal mammalian cells leads to
the appearance of microtubule bundles [25, 26, 31, 32]
(Fig. 3a). This fact has established tau as a bundling factor.
However other facts have nuanced this view: (1) Experi-
mental results showed that the N-terminal domain was not
required for microtubule bundling ([7], Fig. 3a). This is
surprising as this domain is responsible for microtubule
bundling in vitro; (2) Microtubule stabilization by taxol is
sufficient to induce the formation of microtubule bundles
[52], which indicates that Tau, solely via its microtubule-
stabilizing activity, could induce microtubule bundling [7];
(3) When overexpressed in cells, many microtubule part-
ners lead to microtubule bundling while it is not their
primary functions. EB-1 is a protein which recognizes
specifically the growing plus-ends of microtubules. When
artificially overexpressed in cells, EB-1 stabilizes micro-
tubules and leads to the formation of thick bundles [53].
Spastin, a microtubule-severing enzyme, is another exam-
ple of a protein [54] that forms microtubule bundles when
overexpressed and prevented from cutting microtubules in
cells.
To better understand the role of tau on the spatial
organization of microtubules in a cellular context, we
analyzed the formation of microtubule bundles versus the
tau:tubulin fluorescence ratio on microtubule structures in
HeLa cells expressing tau 2N, tau 0N and deltaNT (see
figure S5). The tau:tubulin fluorescence ratio should reflect
the tau:tubulin molar ratio on microtubules. This parameter
is therefore more informative than the percentage of cells
displaying microtubule bundles [7]. At low tau:tubulin
fluorescence ratios, neither of the tau constructs induces
bundling (Figs. 3a, b and S5). In contrast, at high tau:-
tubulin fluorescence ratios, all the tau constructs induce
bundling. The difference between the three tau constructs
lies in the critical tau:tubulin fluorescence ratio required to
induce microtubule bundling (Fig. 3b). Microtubule
bundling appears at a significantly higher expression level
for the longest tau isoform, tau 2N, than for deltaNT and, to
a lesser extent, for the shortest isoform of tau, tau 0N. This
result indicates that the N-terminal part of tau counteracts
microtubule bundling as observed in vitro under macro-
molecular crowding conditions. To exclude the influence of
varying microtubule stability, the same experiments were
repeated in HeLa cells treated with taxol to stabilize
microtubules and the results again indicate a negative
regulation of microtubule bundling by the N-terminal
domain of tau at low tau:tubulin fluorescence ratios
(Fig. 3c, d).
We also considered microtubule bundling after osmotic
shock in taxol-treated HeLa cells. Osmotic stress increases
intracellular macromolecular crowding and leads to the
formation of microtubule bundles, as previously reported
[55]. In line with this, NaCl treatment indeed leads to the
formation of microtubule bundles in control HeLa cells
(figure S6A and B). Interestingly, the percentage of cells
displaying microtubule bundles is not increasing signifi-
cantly between cells expressing tau 2N under control and
hypertonic conditions (figure S6A and B). Again, in cells
displaying a low tau:tubulin fluorescence ratio, the pres-
ence of microtubule bundles after osmotic stress is less
marked than at high tau:tubulin fluorescence ratio (fig-
ure S6C). However cells expressing deltaNT formed
bFig. 1 Tau leads to microtubule bundling in vitro via its N-terminal
domain. a Schematic representation of the tau constructs used in this
study. b Turbidimetry curves recorded in the presence of tubulin and
tau 2N at indicated tau:tubulin molar ratios after raising the
temperature from 5 to 37 C. The increase of plateau value of the
assembly curves in the presence of tau 2N could be the result of three
putative and independent contributions: (1) increase of final micro-
tubule mass, (2) tau aggregation, (3) tau-induced microtubule
bundling [46]. We controlled that tau alone does not increase the
absorbance so that the contribution of tau aggregation can be
excluded. In addition, owing to the magnitude of the increase in the
plateau value observed for tau:tubulin molar ratios of 1:5 and 1:3,
microtubule stabilization cannot solely account for this phenomenon.
Polymerization buffer: 10 mM HEPES–KOH pH 6.8, 30 mM KCl,
20 % glycerol, 1 mM EGTA, 4 mM MgCl2, 1 mM GTP. 20 lM
tubulin were used for microtubule polymerization. c Microtubule
bundling observed via turbidimetry measurements of taxol-stabilized
microtubules after the addition of tau 2N, tau 0N and deltaNT. In the
presence of taxol, only microtubule bundling contributes to the
increase of absorbance. Tau 2N gradually induces microtubule
bundling. DeltaNT does not induce microtubule bundling. Same
buffer as b with 10 lM tubulin and 5 lM taxol. d Statistical analysis
of microtubule bundling obtained from optical microscope images of
taxol-stabilized microtubules deposited on mica in the presence or
absence of tau 2N or deltaNT (see figures S2 for details). The increase
of the normalized fluorescence intensity reveals that tau 2N induces a
massive microtubule bundling at tau:tubulin molar ratio higher than
1:15. Results are mean ± SD (n = 60). Two-tailed t test, **p\ 0.01.
e High resolution imaging by atomic force microscopy shows the
formation of loose microtubule bundles in the presence of tau 2N at a
tau:tubulin molar ratio of 1:15. Such pattern was not observed with
deltaNT. At high tau:tubulin molar ratio (1:3), tau2N leads to the
formation of large bundles. Same conditions as c with taxol-stabilized
microtubules. Scanned area: 5 9 5 lm2. Lower panels represent
higher magnification images of the area corresponding to the dashed
squares
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microtubule bundles whatever they were exposed to
osmotic stress or not. Altogether these results indicate that
the N-terminal domain of tau 2N, at low tau:tubulin ratio,
antagonizes microtubule bundling in a cellular context.
An estimation of the tau:tubulin molar ratio
in axons of mouse cortical neurons reveals that tau
may not trigger but rather prevent the formation
of microtubule bundles
Tau promotes microtubule bundling in HeLa cells at ele-
vated tau:tubulin fluorescence ratios while the N-terminal
domain responsible for tau-mediated cross-bridges clearly
antagonizes their formation at lower ratios. We then
wondered which of these two regimes prevails in axons of
mature primary neurons. To explore this point, we co-
cultured primary mouse cortical neurons and HeLa cells
expressing tau 2N and measured the tau:tubulin fluores-
cence ratio in both axons and transfected HeLa cells
(Fig. 4a). HeLa cells thus serve as internal controls to
gauge the critical tau:tubulin fluorescence ratio for micro-
tubule bundling. We noticed that the tau:tubulin
fluorescence ratio was significantly lower in axons than in
HeLa cells displaying microtubule bundles (Fig. 4a–c). To
make a parallel between in vitro results with those obtained
in cells, we recorded a calibration curve of the measured
tau:tubulin fluorescence ratio on microtubules deposited on
mica versus tau:tubulin molar ratio (Figs. 4d and S2).
Using this calibration curve, the estimated value of the
mean tau:tubulin molar ratio along axons is about 1:45,
which is in line with the values previously reported. By
comparison, in order to trigger microtubule bundling in
HeLa cells, the tau:tubulin molar ratio should be larger
than 1:8 for tau 2N. The tau:tubulin molar ratio in axons of
cultured cortical neurons is thus probably not sufficient to
induce microtubule bundling. These results are in line with
an inhibition of microtubule bundling orchestrated by the
N-terminal domain of tau. However, precautions should be
taken before generalizing these results. The tau:tubulin of
cortical neurons in culture for 7 days may not be repre-
sentative of all neurons. In addition, the tau:tubulin ratio is
not stable along axons and may increase in the apical
region [56]. We thus cannot exclude that tau can initiate
microtubule bundling in specific locations in axons.
Both numerical and analytical analyses predict
that tau could be an efficient microtubule spacer
owing to tau diffusion on microtubules
In the polymer brush model [57], tau is an unstructured
polymer which coats the surface of particles to prevent
their aggregation. For an efficient steric hindrance in the
case of microtubules, scaling laws indicate that about 1 tau
molecule for 6 tubulin dimers is required [40] (see Eq. 6 in
supplementary data 1). The microtubule surface should
then be half-saturated with tau (saturation ratio: 1:3), which
is much too high to be relevant under physiological con-
ditions. Along with this, tau diffuses on microtubules. If
there is no force to keep tau at the interface between
approaching microtubules, tau has the possibility to move
away from the interface of microtubules via thermal dif-
fusion (Fig. 5a). Consequently, tau cannot efficiently block
microtubule bundling at low tau:tubulin ratios in the
polymer brush model.
In the cross-bridge model, tau dimerization via the
N-terminal domain can provide an energy benefit to keep
tau at the interface between microtubules and prevent tau
from bundling under macromolecular crowding conditions
(Fig. 5a). In addition, tau cross-bridges will oppose the
further approach of two interacting microtubules. The
compression of tau cross-bridges at the interface between
approaching microtubules indeed generates a repulsive
force [58] and, accordingly, tau cross-bridges have been
bFig. 2 Tau antagonizes microtubule bundling under macromolecular
crowding conditions. a Variations of absorbance recorded after the
addition of PEG 35K 1 % to taxol-stabilized microtubules in the
absence or presence of tau 2N at indicated concentrations. The
presence of tau 2N prior to adding PEG 35K blocks microtubule
bundling and so even at low tau:tubulin molar ratio (1:30). Buffer:
10 mM HEPES–KOH pH 6.8, 30 mM KCl, 20 % glycerol, 1 mM
EGTA, 4 mM MgCl2, 1 mM GTP, 10 lM tubulin and 5 lM taxol.
b Same experiments as a in the presence of tau 0N or deltaNT.
DeltaNT fails to prevent microtubule bundling by PEG 35K. Tau 0N
prevents microtubule bundling but to a lesser extent than tau 2N.
c Atomic force microscopy images of taxol-stabilized microtubules
after the addition of 1 % PEG 35K for 15 min. In control, PEG 35K
leads to the appearance of tight microtubule bundles. In contrast with
deltaNT, tau 2N inhibits the formation of tight microtubule bundles in
the presence of PEG 35K 1 % for 15 min. Scanned area: 5 9 5 lm2.
d Statistical analyzes of microtubule bundling from optical microcopy
images of taxol-stabilized microtubules deposited on mica in the
presence of tau 2N. The addition of PEG 35K 1 % leads to the
formation of microtubule bundles in control. The presence of tau 2N
inhibits the massive microtubule bundling induced by the addition of
PEG 35K. Results are mean ± SD (n = 60). Two-tailed t test,
**p\ 0.01. e Electron micrographs reveal that microtubules exposed
to 1 % PEG 35K for 15 min form tightly packed bundles. In the
presence of tau 2N, microtubules failed to form tightly packed
bundles after the addition of PEG 35K. In contrast, the presence of
deltaNT does not prevent the formation of tightly packed bundles
under macromolecular crowding conditions. Scale bars 100 nm.
Tau:tubulin molar ratio: 1:8 for both tau 2N and deltaNT. Statistical
measurements of inter-microtubule distances (center to center) inside
bundles under indicated conditions in the presence of 1 % PEG 35K.
The separation distance is larger in the presence of tau 2N.
Interestingly, the packing of microtubule with deltaNT is tighter than
in control conditions. We attributed this fact to the neutralization of
the negatively charged C-terminal tail of tubulin by the positive
residues of deltaNT, which reduces the electrostatic repulsion of
microtubules. Results are mean ± SD, (n[ 95). Two-tailed t test,
**p\ 0.01
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considered as strings [59]. To perform numerical simula-
tions, we considered that tau forms antiparallel cross-
bridges at the interface between microtubules and assumed
that tau dimerization can be disrupted when interacting
microtubules move away from each other. The latter
assumption seems justified as a massive microtubule
bundling was not observed at low tau:tubulin ratios
(Fig. 2). Based on these hypotheses, the results of numer-
ical simulations indicate that tau 2N is an efficient spacer
for microtubules (Fig. 5b, Videos 1–4). Interestingly, tau
diffusion reduces the critical tau:tubulin ratio required to
prevent microtubule bundling. As the microtubule surface
3752 A. Me´phon-Gaspard et al.
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area scanned by tau increases with tau mobility, less tau is
required to keep microtubule separated (Fig. 5b, c). To
emphasize this point, an analytical approach shows that the
number of diffusing tau proteins required to prevent the
formation of microtubule bundles decreases linearly with
the relative mobility of tau, Dtau; =DMT where Dtau, DMT
are the diffusion constants of tau and microtubules,
respectively (see supplementary text, Eq. 5). Interestingly,
increasing the length of the N-terminal domain signifi-
cantly reduces the number of tau molecules required for
keeping microtubule separated (Fig. 5d and Eq. 5 in sup-
plementary data 1).
Discussion
While microtubules form bundles in non-neuronal cells
overexpressing tau, microtubules appear as rather homo-
geneously distributed in axonal sections of mature neurons
[16, 17, 19]. The spatial separation of microtubules most
probably favors long-range transport of vesicles, mito-
chondria and RNA along axons. To explain the spatial
separation of axonal microtubules, tau was then considered
as a microtubule spacer [21, 22]. In the polymer brush
model, the separation between microtubules is due to the
unstructured N-terminal domain of tau which acts as a
repulsive layer. While such a mechanism deserves to be
considered, its application to tau and axonal microtubules
has to be carefully analyzed. The point is that near-satu-
rating concentrations of tau are required to form a
continuous repulsive layer on microtubule surface. In
axons, the tau:tubulin molar ratio ranges between 1:12 and
1:68 [41–43] and, here, an estimation based on calibrated
immunofluorescence in axons of cortical neurons leads to a
tau:tubulin molar ratio of about 1:45. The tau:tubulin molar
ratios found in axons are therefore not sufficient to form a
continuous layer on microtubule surface. Importantly, tau
diffuses on the microtubule lattice. Tau has thus the pos-
sibility to move away from the interface between
microtubules. In the absence of additional factors, micro-
tubules should then form bundles under macromolecule
crowding conditions (Figs. 5a, 6a).
To understand the mechanisms responsible for separat-
ing axonal microtubules, we considered that tau forms
cross-bridges at the interface between microtubules. The
energy benefit of forming cross-bridges allows the specific
location of tau at the microtubule interface and thus pre-
vents tau from moving away (Fig. 1a). At low tau:tubulin
molar ratios, the formation of only few cross-bridges is not
sufficient to trigger the formation of microtubule bundles
by itself. However, when microtubules further approach
from each other, the compression of tau cross-bridges
generates an energy barrier. Consequently, the short-range
attraction force due to macromolecular crowding can no
longer take place (Fig. 6a), which precludes the formation
of tightly packed microtubule bundles. In cells over-ex-
pressing tau, tau-cross-bridges are numerous and
artificially induce microtubule bundling (Fig. 6b). In vitro,
only elevated tau:tubulin molar ratios and moderate ionic
strengths allow the clear detection of microtubule bundles
(Figs. 1 and S3). The biphasic effect of tau on the spatial
organization of microtubules is misleading and led to the
biased view that tau promotes microtubule bundling
in vivo.
Interestingly, thermally-induced movements of tau
allow the exploration of a large surface area on the
microtubule lattice in search for other tau proteins on the
surface of other microtubules. Tau diffusion is thus critical
to prevent microtubule bundling at tau:tubulin molar ratios
well below the ratio required to saturate microtubules
(Figs. 5b, c, 6b).
The unified view on the role of tau in axonal micro-
tubule organization presented in this study provides new
insights into the role of tau in neuronal functions. For
example, tau was reported to impair the long-range trans-
port of vesicles and mitochondria along microtubules via
molecular motors, as observed repeatedly in cells overex-
pressing tau [60–63]. However, both tau diffusion on
microtubules and its ability to form cross-bridges in
between microtubules enable to keep microtubules
bFig. 3 The N-terminal domain of tau antagonizes microtubule
bundling in non-neuronal cells at low tau:tubulin fluorescence ratio.
a Fluorescence microscopy of HeLa cells expressing Tau 2N, Tau 0N
and deltaNT, as indicated in the figure. Anti-tubulin and anti-Tau
immunofluorescences are represented in red and green respectively.
The anti-tau antibody is directed against the C-terminal domain of tau
and recognizes all the tau constructs used in this study. Scale bar
30 lm. b Statistical analyses of the formation of microtubule bundles
in HeLa cells vs tau:tubulin fluorescence ratio for the three tau
constructs. For both cells displaying microtubule bundles or not (see
supplementary figure S7), the mean fluorescence ratios and standard
deviations were determined. For all tau constructs, the ratios of
tau:tubulin fluorescence were significantly different in cells with and
without microtubule bundles as indicated in the figure. **p\ 0.01;
two-tailed t test. Tau 2N induces microtubule bundling at a
significantly higher tau:tubulin fluorescence ratio than deltaNT and
to a lesser extent Tau 0N. The transition between bundling and no
bundling occurs at a critical tau:tubulin fluorescence ratio indicated in
the figures for each tau constructs. The critical fluorescence ratio and
interval boundaries were estimated as the mean and difference
between the ratios leading to 25 and 75 % of cells having microtubule
bundles, respectively. The transition zone between bundling and no
bundling is represented in blue in the figures. c Fluorescence
microscopy of HeLa cells expressing either tau 2N or deltaNT and
treated with 100 nM taxol for 8 h. Microtubule bundling appears as
less marked in cells expressing tau 2N than in cells expressing
deltaNT. Scale bar 30 lm. d Same as b for taxol-treated cells. Again,
a higher tau:tubulin fluorescence ratio is required to induce micro-
tubule bundling in cells expressing tau 2N than deltaNT
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separated at low tau levels. At such low levels, the presence
of tau on microtubules should therefore not constitute an
obstacle for active transport of cargoes.
The consequences of alternative splicing of tau mRNA
and tau phosphorylation on the spatial distribution of
axonal microtubules also deserve to be considered and
Fig. 4 In axons, the tau:tubulin molar ratio is not sufficient to trigger
microtubule bundling and should rather prevent microtubules from
bundling. a Left panel primary mouse cortical neurons were cultured
for 7 days and then co-cultured with HeLa cells expressing Tau 2N
for 8 h. Fluorescence microscopy reveals the expression levels of Tau
in neurons and some Hela cells. The anti-tau and anti-tubulin
antibody fluorescence is represented in red and green, respectively.
The anti-tau antibody recognizes an epitope in the C-terminus of tau
which is conserved in both mouse and human. Scale bar 30 lm. Right
panel fluorescence intensities of anti-tau and anti-tubulin antibodies
along the yellow line represented in the bottom image of the left panel.
The positions of the cells with or without microtubule bundles and the
axon are indicated in the figure. b Images of HeLa cells and a
representative axon sorted by their respective tau:tubulin fluorescence
ratio. In axons, the tau:tubulin fluorescence ratio appears far lower
than in HeLa cells having microtubule bundling. c Statistical analyzes
of the tau:tubulin fluorescence ratio measured in axons (green
triangles) and HeLa cells (circles and squares) as described in
Fig. 3. The axonal tau:tubulin fluorescence ratio is indeed signifi-
cantly lower than in HeLa cells displaying microtubule bundles (we
controlled that the presence of HeLa cells does not change the
tau:tubulin fluorescence ratio measured in cultured neurons). d Cal-
ibration curve of the ratio of tau:tubulin fluorescence vs tau:tubulin
molar ratio, which was measured from microtubules interacting with
recombinant Tau 2N in vitro. Each dot represents the average over ten
different measurements. The putative tau:tubulin molar ratio in axons
was estimated by using the calibration curve and the mean tau:tubulin
fluorescence ratio found in axons (0.17). The critical tau:tubulin
molar ratio required to form microtubule bundles in HeLa cells was
obtained by using the critical tau:tubulin fluorescence ratio for
microtubule bundling (1.15 for tau 2N). The calibration curve was
fitted with a second order polynome using a least square fitting
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could enlighten the process leading to axon degeneration
observed in Alzheimer’s disease. The results present here
show that the tau isoform with the longest N-terminal
domain (2N) is the most potent to prevent microtubules
from bundling under macromolecular crowding conditions.
During neurogenesis, tau isoforms with short N-terminal
domain (0N and 1N) are expressed but their expression is
significantly reduced in adult brain [64]. In mature axons,
the presence of tau 2N could thus be necessary to keep
microtubules homogeneously distributed. The role of the
number of microtubule binding repeats (4R or 3R) may
also matter. 4R isoforms bind to microtubules with a higher
affinity than 3R isoforms but a strong binding also limits
tau diffusion on microtubules. Experimental data are thus
required to clarify whether tau 4R or 3R have a similar
ability to prevent microtubule bundling.
In addition, tau phosphorylation leads to a lower affinity
of tau for microtubules [65], which is considered critical
for the redistribution of tau to the somatodendritic com-
partment and the accumulation of tau aggregates [66]. Our
unified model however provides an alternative view. Tau
phosphorylation events and especially those occurring in
the proline rich and N-terminal domain may alter the
capacity of tau to separate microtubules. An early event in
Alzheimer’s disease could thus be the collapse of axonal
microtubules into tightly packed bundles due to inappro-
priate tau phosphorylation events. Further investigations
should be carried out to explore this hypothesis.
Materials and methods
Preparation of sheep brain tubulin and subtilisin-
treated tubulin
Tubulin was purified from sheep brains and stored at
-80 C in 20 mM MES–KOH, pH 6.9, 0.5 mM DTT,
0.5 mM EGTA, 0.25 mM MgCl2, 3.4 M glycerol, and
0.1 mM GTP. Before use, an additional cycle of poly-
merization was performed, and tubulin was resuspended in
20 mM MES–KOH, pH 6.9, 0.25 mM EGTA, 0.25 mM
MgCl2. Tubulin concentration was determined by spec-
trophotometry using an extinction coefficient
e278 nm = 1.2 9 10
5 M-1 cm-1 [28].
Turbidimetry measurements
The kinetics of microtubule assembly and (or) bundling
was monitored by turbidimetry at 370 nm using an Ultro-
spec 3000 spectrophotometer (GE Healthcare, Fairfield,
CT) equipped with a temperature controller. Microtubule
assembly was obtained after preincubating tubulin samples
on ice for 5 min in polymerization buffer (10 mM HEPES–
KOH pH 6.8, 30 mM KCl, 20 % glycerol, 1 mM EGTA,
4 mM MgCl2, 1 mM GTP) in the presence or absence of
tau. Tubulin polymerization was then initiated by shifting
the temperature to 37 C. Microtubule bundling was
monitored by turbidimetry at 37 C after adding either 1 %
PEG 35K or tau at varying concentrations to taxol-stabi-
lized microtubules in the indicated buffer.
Cloning of tau isoforms
Tau 2N/4R and deltaNT cDNAs were obtained by ampli-
fying hTau40 pET29b plasmid (catalogue no. 16316,
Addgene, Cambridge, MA) either from the beginning or
from P172 to L441 using Phusion Hot Start II High-Fide-
lity DNA Polymerase (catalogue: F-537L, Thermo Fischer
Scientific). The PCR products were first cloned into
pENTR/D-TOPO by TOPO cloning (primers are listed in
Supplemental Table 1) and then moved into pDEST17 by
the LR reaction for recombinant protein expression with a
His-Tag (Life Technologies). To obtain hTau24 three
PCRs was necessary) using Hot Start II High-Fidelity DNA
Polymerase (catalogue: F-537L, Thermo Fischer Scien-
tific). Tau full length plasmid was used as template to
design the primers and to amplify two fragments encoding
hTau24 sequence (accession number NM_016834.4). For
all PCRs, cycling was a 30 s initial denaturation at 98 C,
35 cycles with 30 s denaturation at 98 C and a 30 s
annealing at 72 C and a final extension also at 72 C for
5 min. PCRs product was cloned into pENTR/D-TOPO by
TOPO cloning then moved into pDEST17 by the LR
reaction.
Production of Human Tau Protein
Rosetta-gamiTM 2 competent cells were transformed with
hTau40 (largest isoform), hTau24 (shortest 4R isoform),
and deltaNT (mutant) expressed in Gateway pDESTTM17
Vector (catalogue no. 11803-012, Life technologies).
Bacteria were grown in LB medium in the presence of
100 lg/ml ampicillin and 15 lg/ml Chloramphenicol.
Overexpression was induced at A600 nm = 0.5 with
0.7 mM isopropyl b-D-thiogalactopyranoside, and incuba-
tion was continued for 3.5 h at 37 C. Bacteria were
pelleted by a 10-min, 40009g centrifugation, and the pellet
was resuspended in Buffer A (25 mM Tris–HCl,
25 mM Mes–KOH, 500 mM NaCl, 0.2 mM MgCl2, 1 mM
PMSF, 5 mM DTT, pH 7.5). Bacteria were then disrupted
by sonication, and centrifuged for 10 min (40009g), the
supernatant was then boiled for 20 min, and ultracen-
trifuged at 100,0009g for 45 min at 4 C. Clarified cell
lysate was then loaded on a Ni2? -nitrilotriacetic acid
column (HisTrap HP, 1 9 1 ml, GE Healthcare Life Sci-
ences). The proteins were eluted with 5 column volumes of
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buffer B (25 mM Tris–HCl, 25 mM Mes–KOH, 250 mM
NaCl, 250 mM Imidazole, 0.2 mM MgCl2, 1 mM PMSF,
5 mM DTT, pH 7.5). Purified proteins were then dialyzed
overnight at 4 C to cleave the His-Tag against 20 mM
Tris, 20 mM Mes, 250 mM NaCl, 0.5 mM EDTA, 1 mM
DTT, pH 7.5) using TEV protease (catalogue no. T4455,
SIGMA). This step was followed by a second nickel-
affinity chromatography to remove the uncleaved recom-
binant tau and TEV protease. Fractions of interest were
combined and dialyzed against 25 mM Hepes, 250 mM
NaCl, 0.25 mM DTT, 0.1 mM PMSF, pH 7.4 to eliminate
traces of imidazole. Proteins were concentrated by ultra-
filtration (Corning Spin-X UF 500, 10 kDa cut-off) and
the final concentration of Tau was determined by amino
acid analysis. All of the purification steps were performed
in the presence of complete Protease Inhibitor Cocktail
tablets (catalogue no. 00000001187358000, Roche Applied
Science).
Atomic force microscopy
Samples containing microtubules and tau under specified
conditions were deposited on freshly cleaved mica and
dried for atomic force microscopy (AFM) imaging, using a
protocol that we developed [67]. The electrostatic adsorp-
tion of microtubules on mica is mediated by magnesium
ions present in the buffer. All AFM experiments were
performed in peak force mode with Nanoscope V (Bruker/
Veeco, Santa Barbara, CA). The peak force tapping mode
was performed using silicon tips (Scanasyst-Air-HR, Bru-
ker). The applied force was minimized as much as possible.
Transmission electron microscopy (TEM)
For ultrathin sectioning, microtubules were prepared with
20 lM tubulin with or without 7 lM of tau and (or) 1 %
PEG 35K in 10 mM HEPES–KOH, 50 mM KCl, pH 6.8,
1 mM EGTA, 4 mM MgCl2 and 1 mM GTP, 20 % glyc-
erol. Microtubules were pelleted at 20,0009g for 30 min at
37 C. The pellets were gently resuspended in 10 mM
HEPES–KOH, 50 mM KCl, pH 6.8, 1 mM EGTA, 4 mM
MgCl2 and 1 mM GTP, 20 % glycerol, 1 % glutaralde-
hyde, 0.2 % tannic acid and incubated for fixation for 1 h
at room temperature. Samples were then post-fixed with
1 % osmium tetroxyde in cacodylate buffer 0.1 M, pH 7.3.
After dehydration in ethanol bathes of increasing concen-
trations, pellets were embedded in epoxy resin (Embed-812
Embedding kit #14120, EMS). Collodion-carbon-coated
copper grids were used to collect the ultrathin sections of
40 nm thickness. The sections were then stained sequen-
tially with 2 % uranyl acetate aqueous and Reynold’s
solutions and analyzed in bright field mode using a Zeiss
902 transmission electron microscope. Images were
acquired using a Megaview III CCD camera with the iTEM
software (Olympus Soft Imaging Solution) at a magnifi-
cation of 79,0009.
Immunofluorescence
HeLa cells and (or) neurons were grown on poly-L-lysine-
coated glass coverslips and fixed in ice-cold methanol
immediately followed by fixation in 4 % paraformaldehyde
at 37 C in PBS for 30 min. After fixation, cells were then
washed and incubated for 1 h with mouse monoclonal anti-
tubulin antibody (E7, 1:2000 dilutions) and anti-tau anti-
body (SC-1995, Santa-Cruz, CA). Cells were washed
extensively in PBS and incubated for 1 h with fluo-
rochrome (Alexa Fluor 488 and -555)-coupled secondary
antibodies (Invitrogen) in blocking solution. The protocol
bFig. 5 Numerical simulations of the mechanism by which tau acts as
a microtubule spacer. a Schematic representation of the polymer
brush model and the alternative model proposed based on tau cross-
bridges and tau diffusion. (1) In the polymer brush model, tau can
move away from the interface between microtubules and thus cannot
prevent microtubule bundling under macromolecular crowding con-
ditions, unless sterical hindrance prevents tau movements at elevated
tau:tubulin molar ratios. (2) Cross-bridging of tau at the interface
between microtubule provides an energy benefit to place tau at the
interface between microtubule. Tau cross-bridges then keep micro-
tubules at distance and prevent short-range attraction between
microtubules under macromolecular crowding conditions. b Numeri-
cal simulations of the spatial distribution of 10 microtubules moving
on a 300 9 300 nm2 area. The number of tau molecules per
microtubule, N, and the relative tau mobility, Dtau
DMT
; are as indicated
in the figure. We remarked that both increasing the number of tau
proteins per microtubule and the tau diffusion decreases the
occurrence of bundling. rp = 5 nm (range of excluded volume
interactions); rc = 15 nm (range of tau cross-bridges). Number of
iterations: 105. L the length of the microtubule, is 500 nm. See
supplementary data 1 for details about the model. Here are
represented the transverse views of the microtubule array. Tau
molecules having different positions along microtubules are then
projected on the section view. Dtau,/DMT values ranging from 2 to 20
were used for the numerical simulations. This choice is based on the
theoretical diffusion constant of a cylindrical molecule (Eq. 1,
supplemental data 1), the estimated value of the cytoplasm viscosity
and the varying length of microtubules (see supplemental data 1 for
details). However, as DMT in axons has not been measured, these
values may be considered as arbitrary. c Number of bundled
microtubules after completion of the numerical simulations vs the
number of tau proteins per microtubule and the relative tau mobility
along microtubules (Dtau/DMT). Same conditions as b. d Numerical
simulations indicating the number of bundled microtubules among 20
microtubules moving on a 350 9 350 nm2 area vs the range of tau
cross-bridges, rc. Number of iterations: 10
5. Dtau/DMT = 3. The other
parameters are the same as B)
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used to measure the tau:tubulin fluorescence ratios on
microtubule structures is described in figure S5.
In vitro, microtubules were polymerized as described in
‘‘Turbidimetry measurements’’ and deposited on freshly
cleaved mica. Samples were fixed with 4 %
paraformaldehyde in PBS at 37 C for 10 min. After fix-
ation, samples were then washed three times in PBS and
prepared for immunofluorescence as described above. The
tau:tubulin fluorescence ratios were measured as described
in figure S2.
Co-culture of neurons and HeLa cells
Cortical neurons from embryonic mice (E19) were pre-
pared as described previously [68] and grown on Poly-L-
ornithine-coated (Sigma-Aldrich) 14 mm coverslips at a
density of 100,000 cells/coverslips in Neurobasal media,
supplemented with 2 % B27, 2 mM L-glutamine. Hela
cells previously transfected with 2N tau by using Lipo-
fectamine 2000 (Invitrogen) were co-cultured on neurons
at 7-day in vitro (DIV) for 8 h.
Fig. 6 Spatial organization of microtubules in the presence of tau
under macromolecular crowding conditions. a Schematic curves
representing forces vs separation distance between microtubules. 1
Macromolecular crowding induces a strong short-ranged attraction
(r\ 5 nm, average size of proteins) and the formation of tightly
packed microtubule bundles. 2 The formation of tau cross-bridges
between microtubules generates a long-ranged attraction (about
20 nm). However the compression of tau cross-bridges generates a
repulsion force at shorter distances. 3 By combining the forces due to
macromolecular crowding and tau cross-bridges, we notice the
appearance of an energy barrier which could prevent microtubules
from collapsing into tight bundles in axons. b Spatial organization of
microtubules at various tau:tubulin molar ratios. 1 In the absence of
tau or at very low tau:tubulin molar ratios (\1:60 for tau 2N, in vitro),
macromolecular crowding induces the collapse of microtubules into
tight bundles. 2 At moderate tau:tubulin molar ratios (from about 1:60
to 1:15, in vitro), transient tau cross-bridges keep microtubules
separated and prevent the formation of tightly packed microtubule
bundles. No massive bundling is observed. We propose that this
regime prevails in axons. 3 At elevated tau:tubulin ratios ([1:15), the
formation of many tau cross-bridges induces the assembly of
microtubule bundles in which the spacing between microtubules is
about 15–20 nm. This regime prevails when tau is strongly over-
expressed in HeLa cells
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